Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-039582
Filing Date
2021-06-10
Accepted
2021-06-10 17:33:25
Documents
2
Period of Report
2021-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2152
2 POA DOCUMENT poa.txt EX-24.3_991904 2916
  Complete submission text file 0001209191-21-039582.txt   6448
Mailing Address AMGEN INC. ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
PERLMUTTER ROGER M (Reporting) CIK: 0001184228 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38853 | Film No.: 211009136

Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Issuer) CIK: 0001426332 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations